QDEL
QuidelOrthoANasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
LEX, High-Sensitivity Troponin, and VITROS 450 could improve the portfolio mix and restore growth if launches gain adoption, while Immunohematology's Q1 growth provides a partial offset to respiratory weakness.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +25.5.
What can break
Final China NHSA IVD pricing rules and implementation timing remain uncertain.
Momentum
89
Value
54
Sentiment
62
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $20.50 · Bull $25.00 · Bear $13.50
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-18 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $20.50
Why
Momentum89 · Δ7d +25.5
Value54 · Δ7d +0.3
Sentiment62 · Δ7d +8.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
89
26% active weight
Current posture
7d trendImproving
Δ7d
+25.5
Δ21d
+62.6
Value
54
39% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
+0.0
Sentiment
62
34% active weight
Current posture
7d trendImproving
Δ7d
+8.5
Δ21d
-40.0
Why this grade
Composite grade A. Momentum 89.5 / Value 54.0 / Sentiment 62.0
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$1.13B
Beta
0.68
Shares Out
68.19M
P/E (TTM) · Derived
-1.0
P/S (TTM)
0.75
P/FCF (TTM)
106.34
Rev YoY
-10.7%
EPS YoY
+615.2%
Gross Margin
+38.0%
Op Margin
-35.3%
Net Debt
$2.66B
Current Ratio
1.43
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology